Skip to main content
Journal for Immunotherapy of Cancer logoLink to Journal for Immunotherapy of Cancer
. 2022 Apr 20;10(4):e003289corr1. doi: 10.1136/jitc-2021-003289corr1

Correction: CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment

PMCID: PMC9021761  PMID: 35444063

Seyfrid M, Maich WT, Shaikh VM, et al. CD70 as an actionable immunotherapeutic target in recurrent glioblastoma and its microenvironment. J Immunother Cancer 2022;10:e003289. doi: 10.1136/jitc-2021-003289.

This article has been corrected since it was first published to correct author name Muhammad Vaseem Shaikh.


Articles from Journal for Immunotherapy of Cancer are provided here courtesy of BMJ Publishing Group

RESOURCES